Matches in Nanopublications for { ?s ?p "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP282557.RAydDzQWkKx8rjoxRKKYqCCSSWHskr8ZH4mF2WwznAD0I130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282557.RAydDzQWkKx8rjoxRKKYqCCSSWHskr8ZH4mF2WwznAD0I130_provenance.
- NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525924.RAh4jSq1fNgTTIsGLVqMX8j4xl8XfkhDXXR19Nesgl9MA130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP545736.RAJGZZb4zqir5ukTv17tLCxR-se-mSnKxY4uYx9DbCfOA130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545736.RAJGZZb4zqir5ukTv17tLCxR-se-mSnKxY4uYx9DbCfOA130_provenance.
- NP896779.RAy0qYDtHOiKyWDbBGzKV51bGUe0njBrvtvmKHJwQm6TE130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896779.RAy0qYDtHOiKyWDbBGzKV51bGUe0njBrvtvmKHJwQm6TE130_provenance.
- NP545735.RA9rdaNk8OLtx5aurRuUs1boY9OHIyLkYOdS3mqJlZpcw130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545735.RA9rdaNk8OLtx5aurRuUs1boY9OHIyLkYOdS3mqJlZpcw130_provenance.